運達科技(300440.SZ)擬捐贈101萬元支持新型冠狀病毒肺炎疫情防控
格隆匯2月19日丨運達科技(300440.SZ)公佈,自新型冠狀病毒肺炎疫情爆發以來,公司高度關注疫情發展,面對當前嚴峻的疫情形勢,積極投身疫情防控工作,並在做好企業和員工防護、積極組織復工復產的同時,切實履行上市公司社會責任。2020年2月19日,公司第三屆董事會第三十五次會議審議通過了《關於對外捐贈支持新型冠狀病毒肺炎疫情防控的議案》,決定向湖北省慈善總會捐贈現金101萬元人民幣,用於支持湖北省新型冠狀病毒感染的肺炎疫情防疫工作。在款項到賬後,定向捐贈於武漢市金銀潭醫院,用於急購醫用防護用品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.